Corporate News     11-Jan-24
Unichem Laboratories receives USFDA approval for Doxazosin tablets
Unichem Laboratories has received ANDA approval for its Doxazosin Tablets USP, 1 mg, 2 mg, 4 mg and 8 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Cardura® (Doxazosin) Tablets, 1 mg, 2 mg, 4 mg and 8 mg, of Viatris Specialty, LLC.

Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure. The product will be commercialized from Unichem's Goa Plant.

Previous News
  Unichem Laboratories reports consolidated net profit of Rs 9.26 crore in the June 2024 quarter
 ( Results - Announcements 08-Aug-24   13:51 )
  Unichem Laboratories Ltd leads losers in 'A' group
 ( Hot Pursuit - 02-Aug-21   15:00 )
  Unichem Laboratories schedules board meeting
 ( Corporate News - 01-Aug-22   15:58 )
  Unichem Laboratories receives downgrade in LT credit ratings
 ( Corporate News - 19-Sep-22   16:27 )
  Ipca Laboratories receives CCI approval for acquisition of upto 26% stake in Unichem Lab
 ( Corporate News - 28-Jul-23   09:18 )
  Unichem Laboratories receives USFDA approval for Tadalafil Tablets
 ( Corporate News - 27-Mar-19   18:07 )
  Unichem Laboratories reports standalone net loss of Rs 24.86 crore in the September 2019 quarter
 ( Results - Announcements 02-Nov-19   17:02 )
  Unichem Labs gains on proposal to consolidate USA generics formulations business under one entity
 ( Hot Pursuit - 23-Sep-24   09:26 )
  Unichem Laboratories receives reaffirmation in ratings for LT bank facilities
 ( Corporate News - 26-Nov-21   12:53 )
  Unichem Laboratories reports consolidated net loss of Rs 63.93 crore in the December 2022 quarter
 ( Results - Announcements 06-Feb-23   16:14 )
  Unichem Laboratories receives ANDA approval for Atenolol and Chlorthalidone Tablets
 ( Corporate News - 30-Nov-20   13:13 )
Other Stories
  Adani Ports records 14% growth in cargo volumes in September 2024
  03-Oct-24   09:37
  SignatureGlobal India launches new project in Gurugram
  03-Oct-24   09:34
  Biocon Biologics refinances debt through USD bonds and syndicated term loan
  03-Oct-24   09:29
  RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
  03-Oct-24   09:26
  Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
  03-Oct-24   09:23
  Transformers & Rectifiers India wins order of Rs 565 cr
  03-Oct-24   09:07
  Tata Motors records 12% decline in Q2 sales
  01-Oct-24   18:04
  Tata Motors records 15% decline in September sales
  01-Oct-24   17:55
  Man Infra set to launch its highly anticipated Vile Parle project
  01-Oct-24   17:48
  Padam Cotton Yarns to declare Quarterly Result
  01-Oct-24   17:39
Back Top